CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Exercise or conversion Director acquired 11,184 shares (option exercise)
- 4 Exercise or conversion Director acquired 13,958 shares (option exercise)
- 4 Exercise or conversion Director acquired 11,184 shares (option exercise)
- 4 Exercise or conversion Director acquired 11,184 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP Reg. & Quality sold 30,025 shares at $6.50 ($195,163)
- 4 Open-market sale Chief Legal Officer sold 20,351 shares at $5.67 ($115,288)
- 4 Exercise or conversion Chief Scientific Officer acquired 94,800 shares (option exercise)
- 4 Open-market sale SVP Reg. & Quality sold 26,684 shares at $3.59 ($95,921)
- 4 Open-market sale Chief Legal Officer sold 26,535 shares at $3.59 ($95,385)
- 4 Open-market sale Chief Commercial Officer sold 23,500 shares at $3.59 ($84,475)
- 4 Open-market sale President and CEO sold 108,011 shares at $3.59 ($388,267)
- 4 Open-market sale Chief Financial Officer sold 26,625 shares at $3.59 ($95,709)
- 4 Open-market sale Chief Scientific Officer sold 17,500 shares at $3.59 ($62,907)
Page 12 of 36 · 701 filings